While the "start-ups" incubated at Institut Curie are above all synonymous with hope for improved treatments and quality of life for patients, they also contribute to the influence of the economy and to highlighting entrepreneurial vocations, particularly for researchers who wish to move outside the academic world.
This is the case of Julien Autebert, a former researcher at Institut Curie, who became co-founder of Inorevia. This MedTech company uses microfluidic technology developed at Institut Curie to miniaturize and automate sample preparation protocols, saving laboratories valuable time and money.
